Clinical Trial

A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents

Name: A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents — clinical trial record (NCT06863987)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 3

View on ClinicalTrials.gov →

Summary

This study was an randomized, double-Blind, placebo-controlled, multicenter Phase II/III study.

Trial Details

NCT Number	NCT06863987
Lead Sponsor	Shandong New Time Pharmaceutical Co., LTD
Conditions	Essential Hypertension
Enrollment	342 participants
Start Date	2025-02-05
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-03-07